180x77

About the Journal

SKIN is a peer-reviewed, open access, online only journal dedicated to providing free access globally to disseminate dermatological knowledge. Authors retain copyright in their articles, licensing publication of their content through use of Creative Commons CCBY license. The journal does not charge fees, and is supported by the National Society for Cutaneous Medicine. 


Read More

Current Issue

Vol. 9 No. 1 (2025): January 2025 Issue

Published: 2025-01-13

Clinical Management Recommendations

The Role of Image-Guided Superficial Radiation Therapy in the Treatment of Nonmelanoma Skin Cancer

Danny Zakria, Joshua Burshtein, Milaan Shah, Clay Cockerell, Gary Goldenberg, Mark Nestor, Deborah Sarnoff, Susan Weinkle, Darrell Rigel, James Q. Del Rosso

Page 2042-2054

In-Depth Reviews

Original Research

Research Letters

Comparing Improvements in Biopsy Decision Making with Electrical Impedance Spectroscopy Between US and German Dermatologists

Danny Zakria, Nicholas Brownstone, Milaan Shah, Joshua Burshtein, Lauren DeBusk, Angela Rosenberg, Darrell Rigel

Page 2082-2086

The Safety Profile of Acne Supplements: Analysis of Active Ingredients

Sasan Noveir, Jayden Galamgam, Carol Cheng

Page 2093-2095

The Rise of TikTok Facial Filler Influencers: Implications for Demand and Practice

Sheila Sharifi, Isabel Rodriguez, Lauren Dender, Keyvan Nouri

Page 2103-2105

Brief Articles

Acute Generalized Exanthematous Pustulosis after Oral Antihistamine

Hannah Riva, Martin Giandoni, Frank Celis, Cynthia Reyes Barron

Page 2116-2119

Eruptive Melanocytic Nevi Secondary to Chemotherapy in a Pediatric Patient a Case Report

Chloe Haverkamp, Rafael Mojia-Ruiz, Michael Lavery

Page 2120-2124

Vulvar Porocarcinoma with Inguinal Nodal Recurrence: A Case Report

Hannah J Porter, Nadeem Marghoob, Hayden Christensen, Matthew Dinehart, Conor O'Neill, Mark Wick, Laura Greene, Christine H Weinberger

Page 2125-2129

Improvement of Suspected Linear Morphea seen with Topical Ruxolitinib

Shivkar Amara, Miyahra Lopez, Mark Lebwohl

Page 2130-2133

A Rare Case of Pemphigoid Gestationis

Sonia Patel, Lauren Okon

Page 2139-2144

Representation and Quality of Acne-Related Content on Social Media

Samantha Zoltan, Nanette Silverberg

Page 2145-2148

SKINmages: Clinical Images in Dermatology

Elastic Garment Bands in an Adult

Sara Attari, Margaret Newsome, Matthew Belcher

Page 2149-2151

Poster Presentations from FC24 Dermatology Conference®: Psoriasis

Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study

April Armstrong, Sarah Lonowski, David Fivenson, William Malatestinic, Mwangi James Murage, Meghan Feely McDonald, Ali Sheikhi Mehrabadi, Joseph F. Merola

Page s509

Atopic Dermatitis

Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe ​ Atopic Dermatitis: Results Up to 3 Years From ADjoin

Emma Guttman-Yassky, Alan Irvine, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Lynda Spelman, Jonathan Silverberg, Heidi Crane, Hany Elmaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Evangeline Pierce, Helena Agell, Diamant Thaçi

Page s510

Lebrikizumab Confirms a Consistent Safety Profile in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: ​ Data From 11 Trials With Over 3000 Patient-Years of Exposure

Linda Stein Gold, Eric Simpson, Diamant Thaçi, Alan Irvine, Marjolein de Bruin-Weller, Gaia Gallo, Maria Lucia Buziqui Piruzeli, Hany Elmaraghy, Jinglin Zhong, Sonia Montmayeur, Ruth Coll, Mark G. Lebwohl

Page s511

Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial

Jonathan Silverberg, Lindsay Ackerman, Jerry Bagel, Linda Stein Gold, Andrew Blauvelt, David Rosmarin, Raj Chovatiya, Matthew Zirwas, Gil Yosipovitch, Jill Waibel, Jenny E. Murase, Ben Lockshin, Jamie Weisman, Amber Reck Atwater, Jennifer Proper, Maria Silk, Evangeline Pierce, Maria Lucia Buziqui Piruzeli, Sonia Montmayeur, Christopher Schuster, Jinglin Zhong, Maria Jose Rueda, Sreekumar Pillai, Eric Simpson

Page s512

Assessing Post-Inflammatory Pigmentation in Atopic Dermatitis: Reliability of the PDCA-Derm™

Andrew Alexis, Evangeline Pierce, Andrea Cohee, Sylvia Su, Amber Reck Atwater, Maria Jose Rueda, Sonia Montmayeur, Brittany Klooster, Caitlyn Lowe, Jonathan Silverberg

Page s514

Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study

Andrew Alexis, Ali Moiin, Jill Waibel, Paul Wallace, David Cohen, Vivian Laquer, Pearl Kwong, Amber Reck Atwater, Jennifer Proper, Maria Silk, Evangeline Pierce, Sreekumar Pillai, Maria Jose Rueda, Angela Moore

Page s515

Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life

Raj Chovatiya, Eric Simpson, Tilo Biedermann, Leon Kircik, Vivian Y. Shi, Ignasi Figueras-Nart, Marta Casillas, Gaia Gallo, Yuxin  Ding, Hong  Zhang, Evangeline  Pierce, Helena  Agell, Christian  Vestergaard

Page s516

Lebrikizumab vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-analysis of Short-term Efficacy

Jonathan Silverberg, Thomas Bieber, Amy Paller, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Peter Foley, Martin Dossenbach, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Raj Chovatiya

Page s517

Race and Ethnicity Related Variations in the Social Impact and Stigma of Atopic Dermatitis Among Adults With AD: US-based Patient Survey

Candrice Heath, Bryan Dosono, Vivian Y. Shi, Jennifer Soung, Wendy Smith Begolka, Amber Reck Atwater, Evangeline Pierce, Elizabeth Bacci, Julia Correll, Melissa Constantine, Raj Chovatiya

Page s518

Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates

Jonathan Silverberg, Alan Irvine, Peter Foley, James Del Rosso, Luis Puig, Linda Stein Gold, Martin Dossenbach, Marta Casillas, Gaia Gallo, Buelent Akmaz, Kim Rand

Page s519

Alopecia

Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials

Justin Ko, Amy McMichael, Maria Hordinsky, Thierry Passeron, Yutaka Shimomura, Samuel Ogwu, Rukhsar Chughtai, Najwa Somani, Brett King

Page s520

Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata

Brett King, Maryanne Senna, Manabu Ohyama, Rodney Sinclair, Najwa Somani, Yves Dutronc, Na Lu, Yun-Fei Chen, Jakub P. Jedynak, Andrew Buchanan, Bianca M. Piraccini

Page s521

Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials

Maryanne Senna, Susan Taylor, Bianca M. Piraccini, Jerry Shapiro, Najwa Somani, Jakub P. Jedynak, Samuel Ogwu, Andrew Buchanan, Brittany Craiglow, Manabu Ohyama

Page s522

Understanding the Experience of Healthcare Access and Health-Related Impacts among Individuals with Alopecia Areata

Candrice R. Heath, Lisa Anderson, Shamsha Damani, Elizabeth D. Bacci, Andrew Buchanan, Julia R. Correll, Evangeline J. Pierce, Melissa L. Constantine, Beth Mitchell, Raj Chovatiya

Page s523

Miscellaneous

Post-Hoc Analyses Support Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Uncontrolled Eosinophilic Asthma and Prior Exacerbations

Jonathan Corren, Stanley J. Szefler, Ellen Sher, Phillip Korenblat, Weily Soong, Nicola A. Hanania, Gary Berman, Guy Brusselle, Ralph Zitnik, Chitra R. Natalie, Kimberly Siu, Wen-Shuo Wu, Meihua Qiao, Peter Lio, April W. Armstrong

Page s524

View All Issues